Using oral molecular hydrogen supplements to combat microinflammation in humans: a pilot observational study.
In a laboratory model, compared to HRW and CaH2, OSHCs demonstrated a prolonged reduction in ORP for 60 minutes in vitro and enabled a regulated release of hydrogen over 24 hours. The authors concluded that oSHCs supplementation may exert anti-inflammatory and antioxidant…
Read Article